| (Values in U.S. Thousands) | Dec, 2017 | Sep, 2017 | Jun, 2017 | Mar, 2017 | Dec, 2016 |
| Sales | -9,999,000 | 13,670 | 13,020 | 12,000 | 10,580 |
| Sales Growth | -73,245.57% | +4.99% | +8.50% | +13.42% | -7.27% |
| Net Income | -9,999,000 | 420 | -2,310 | 20 | -4,210 |
| Net Income Growth | -2,380,814.29% | +118.18% | -11,650.00% | +100.48% | -1,175.76% |
Enzymotec Ltd (ENZY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Enzymotec, Ltd. provides specialty lipid-based products and solutions. The Company develops, manufactures and markets bio-functional lipid ingredients as well as final products. It serves pharmaceuticals and nutrition industries worldwide. Enzymotec, Ltd. is based in Migdal HaEmeq, Israel.
Fiscal Year End Date: 12/31